Department of Biomedical Engineering
National University of Singapore
The TTE group leverages bioengineering tools to engineer in vitro and ex vivo tumors for personalized drug testing
Principal Investigator
Eliza FONG, Ph.D.
-
Assistant Professor, Department of Biomedical Engineering
-
PI, The N.1 Institute for Health
-
Associate Investigator, Cancer Science Institute of Singapore
-
Ph.D. Thesis Advisor, Integrative Sciences and Engineering Programme (ISEP), NUS Graduate School
National University of Singapore
Email: BIEFLSE@NUS.EDU.SG
EDUCATION
2010-2015
Ph.D. in Bioengineering, Rice University, Houston, Texas
2010-2015
Howard Hughes Medical Institute, Med-Into-Grad Pre-Doctoral Fellow in Cancer Diagnostics and Therapeutics, Rice University and The University of Texas, MD Anderson Cancer Center, Houston, Texas
2005-2009
Bachelor of Engineering in Bioengineering (First Class Honors), National University of Singapore, Singapore
SELECTED AWARDS
L’Oréal Singapore For Women In Science National Fellowship Finalist
National University of Singapore - Early Career Award
Singapore Women's Weekly Great Women of Our Time nominee
Bioscience Research Collaborative, Collaborative Shared Prize
National University of Singapore - Overseas Graduate Scholarship
National Medical Research Council, Open Fund - Young Individual Research Grant
National Medical Research Council, Individual Research Grant
ABOUT the PI
I lead a diverse and inclusive team of trainees to develop platforms that contribute to improved drug development in cancer, and the possibility of personalizing cancer medicine through functional precision oncology. Together, we strive to overcome some of the bottlenecks in in vitro and ex vivo tumor modeling to make a difference to the treatment of cancer patients.